Literature DB >> 3479819

Disseminated infection with Trichosporon beigelii.

D M Walling1, D J McGraw, W G Merz, J E Karp, G M Hutchins.   

Abstract

Two cases of systemic infection with Trichosporon beigelii are reported. Both patients had acute leukemia and were receiving cytotoxic and antibiotic drug therapy, which included amphotericin B, at the time of sepsis. Although clinical isolates of the organisms were found to be sensitive to amphotericin B in vitro, both patients died from severe, widespread fungal infection. The pathologic findings in these two cases suggest that the host response to trichosporon infection is a granulomatous inflammation. Trichosporon is a virulent opportunistic pathogen that may originate from the gastrointestinal tract damaged by cytotoxic therapy in the patient with aplasia. Despite aggressive antifungal therapy, survival is most closely related to recovery of the host's hematopoietic system.

Entities:  

Mesh:

Year:  1987        PMID: 3479819     DOI: 10.1093/clinids/9.5.1013

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  16 in total

1.  High-throughput detection of pathogenic yeasts of the genus trichosporon.

Authors:  Mara R Diaz; Jack W Fell
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

2.  Disseminated trichosporonosis: meeting the challenge.

Authors:  E Anaissie; G P Bodey
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-09       Impact factor: 3.267

Review 3.  Fungal infections of the immunocompromised host: clinical and laboratory aspects.

Authors:  C E Musial; F R Cockerill; G D Roberts
Journal:  Clin Microbiol Rev       Date:  1988-10       Impact factor: 26.132

4.  Distinction of deep versus superficial clinical and nonclinical isolates of Trichosporon beigelii by isoenzymes and restriction fragment length polymorphisms of rDNA generated by polymerase chain reaction.

Authors:  B J Kemker; P F Lehmann; J W Lee; T J Walsh
Journal:  J Clin Microbiol       Date:  1991-08       Impact factor: 5.948

5.  Multidrug-resistant Trichosporon asahii infection of nongranulocytopenic patients in three intensive care units.

Authors:  D G Wolf; R Falk; M Hacham; B Theelen; T Boekhout; G Scorzetti; M Shapiro; C Block; I F Salkin; I Polacheck
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

6.  Evaluation of four commercial systems for identification of medically important yeasts.

Authors:  I Schuffenecker; A Freydière; H de Montclos; Y Gille
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-04       Impact factor: 3.267

7.  Disseminated trichosporonosis in a neutropenic murine model.

Authors:  D Hospenthal; T Belay; P Lappin; A Rogers; M Kennedy
Journal:  Mycopathologia       Date:  1993-05       Impact factor: 2.574

8.  Trichosporon cutaneum fungemia in patients with acute myeloblastic leukemia and measurement of serum D-arabinitol, Candida antigen (CAND-TEC), and beta-D-glucan.

Authors:  S Morimoto; C Shimazaki; H Goto; Y Hirata; T Tasumi; N Yamagata; T Hirata; E Ashihara; T Inaba; N Fujita
Journal:  Ann Hematol       Date:  1994-03       Impact factor: 3.673

9.  Patterns of morphologic variation among isolates of Trichosporon beigelii.

Authors:  J W Lee; G A Melcher; M G Rinaldi; P A Pizzo; T J Walsh
Journal:  J Clin Microbiol       Date:  1990-12       Impact factor: 5.948

Review 10.  Disseminated Trichosporon beigelii infection in patients with malignant diseases: immunohistochemical study and review.

Authors:  T Tashiro; H Nagai; P Kamberi; Y Goto; H Kikuchi; M Nasu; S Akizuki
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-03       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.